![A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial - Clinical Therapeutics A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/634f1049-4f74-41b4-98b9-d2bccca4ac64/gr2_lrg.jpg)
A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial - Clinical Therapeutics
![WO2018085256A1 - Effective dosing of a child for the treatment of adhd with methylphenidate - Google Patents WO2018085256A1 - Effective dosing of a child for the treatment of adhd with methylphenidate - Google Patents](https://patentimages.storage.googleapis.com/3b/87/a4/ffa4f81a593949/imgf000034_0001.png)
WO2018085256A1 - Effective dosing of a child for the treatment of adhd with methylphenidate - Google Patents
![Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies | BMC Psychiatry | Full Text Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies | BMC Psychiatry | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-244X-13-237/MediaObjects/12888_2013_Article_1428_Fig3_HTML.jpg)